Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy

LEXINGTON, Mass., May 10, 2018 -- (Healthcare Sales & Marketing Network) -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-media... Biopharmaceuticals, Ophthalmology, Personnel Aldeyra Therapeutics, reproxalap, conjunctivitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news